Announced Wed, 21 May · 18:04 IST

Swaraj Shares and Securities Private Limited ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement under Regulation ....

Listed Co AcquisitionOpen Offer TriggeredStrategic Transactions View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

M/s Atibha Agriseeds Private Limited (Acquirer) has announced an Open Offer to acquire up to 3,90,000 equity shares (26.00% of voting capital) of Chemo Pharma Laboratories Limited from public shareholders at ₹110 per share, totaling a maximum consideration of ₹4.29 crore. The offer is triggered under SEBI (SAST) Regulations following a Share Purchase Agreement dated February 18, 2025, where the Acquirer agreed to buy 4,18,281 shares (27.89%) from selling promoters Citric India Limited and Mrs. Shanta Somani. This filing is a Pre-Offer Advertisement cum Corrigendum published on May 21, 2025, correcting the offer closing date to June 4, 2025. The tendering period runs from May 22, 2025, to June 4, 2025. The Independent Directors Committee has deemed the offer price fair and reasonable.

Likely market impact

Public shareholders of Chemo Pharma Laboratories can tender their shares at ₹110 between May 22 and June 4, 2025. The offer represents a mandatory open offer triggered by the Acquirer's purchase of a controlling stake from promoters, signaling a change in ownership of the listed company.